A Phase II/III Trial of Chemotherapy alone versus Chemotherapy Plus SCH58500 in Newly Diagnosed Stage III Ovarian and Primary Peritoneal Cancer Patients with >=0.5cm and <=2 Residual Disease following Surgery

  • Kerr, David (Principal Investigator)
  • Poole, Christopher (Co-Investigator)

Project Details

Short titleA Phase II/III Trial of Chemotherapy alone versus Chemotherapy Plus SCH58500 in Newly Diagnosed Stage III Ovarian and Primary Peritoneal Cancer Patients with >=0.5cm and <=2 Residual Disease following Surgery
StatusFinished
Effective start/end date1/07/99 → 31/07/02

Funding

  • SCHERING-PLOUGH LTD